top banner image  

topleft corner image     top right corner image
 


bullet

JACC Homepage JACC Imaging Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

     top nav image

     

J Am Coll Cardiol Intv, 2008; 1:535-544, doi:10.1016/j.jcin.2008.08.004
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by John, M. C.
Right arrow Articles by Finn, A. V.
Right arrow Search for Related Content
PubMed
Right arrow Articles by John, M. C.
Right arrow Articles by Finn, A. V.

Clinical Research

Differential Healing Responses in Polymer- and Nonpolymer-Based Sirolimus-Eluting Stents

Michael C. John, MPH*, Rainer Wessely, MD{ddagger}, Adnan Kastrati, MD{ddagger}, Albert Schömig, MD{ddagger}, Michael Joner, MD{dagger}, Mayu Uchihashi, BA*, Johanna Crimins, BA*, Scott Lajoie*, Frank D. Kolodgie, PhD{dagger}, Herman K. Gold, MD*, Renu Virmani, MD{dagger}, Aloke V. Finn, MD*,*

* Cardiac Unit, Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts
{dagger} CVPath, International Registry of Pathology, Gaithersburg, Maryland
{ddagger} Deutsches Herzzentrum and Med. Klinik rechts der Isar, Technische Universität, Munich, Germany

* Reprint requests and correspondence: Dr. Aloke V. Finn, Department of Internal Medicine, Emory University School of Medicine, Emory Crawford Long Hospital, 550 Peachtree Street NE, Atlanta, Georgia 30308 (Email: avfinn{at}emory.edu).

Objectives: We compared the healing and inflammatory responses of polymer-free bare-metal stents (BMS), polymer-free sirolimus-eluting stents (SES) and polymer-free sirolimus-eluting stents plus estradiol (SES+ED) to Cypher drug-eluting stents (CDES) in a rabbit model of overlapping stent placement.

Background: Inflammatory responses to polymers and delayed healing remain important safety issues associated with CDES. Whether nonpolymeric stents that elute sirolimus or sirolimus and estradiol provoke less inflammation and heal better is unknown.

Methods: Twenty-eight rabbits received 2 overlapping stents in each iliac artery: SES, SES+ED, BMS, or CDES, and vessels were harvested at 28 days for histology and scanning electron microscopy.

Results: Although similar at nonoverlapping segments, neointimal thickness within the overlap site of CDES was significantly less than in SES, SES+ED, and BMS (0.07 ± 0.04 mm vs. 0.16 ± 0.03 mm, 0.14 ± 0.03 mm, and 0.15 ± 0.03 mm, p < 0.0001). Endothelialization was greater in SES, SES+ED, and BMS compared with CDES in nonoverlapping sections (80.0 ± 5.0% vs. 95.3 ± 5.0%, 97.5 ± 2.5%, and 96.7 ± 3.8%; p = 0.0028) and overlapping sections (85.8 ± 2.9% vs. 90.8 ± 6.3%, 89.2 ± 6.3%, and 48.3 ± 2.9%; p < 0.0001). The number of luminal eosinophils was also less in overlapping sections of SES, SES+ED, and BMS versus CDES but was similar in nonoverlapping sections.

Conclusions: Polymer-free stents coated with SES or SES+ED result in less robust neointimal suppression but markedly improved arterial healing compared with CDES in the rabbit model.

Key Words: stents • endothelium • polymer

Abbreviations and Acronyms
  BMS = bare-metal stent(s)
  CDES = Cypher drug-eluting stent(s)
  DES = drug-eluting stent(s)
  IL = interleukin
  ISAR = individualizable drug-eluting stent system to abrogate restenosis
  LM = light microscopy
  OC = organoid culture
  SEM = scanning electron microscopy
  SES = sirolimus-eluting stent(s)
  SES+ED = sirolimus-eluting stent(s) plus estradiol
  VEGF = vascular endothelial growth factor






 
   
 
home link current link search link archive link topics link cardiology careers link